MedTrace Logo

Genomic Profiling Assay in Phase I

NCT02437617 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2021-06-14

No results posted yet for this study

Summary

The goal of this research study is to collect and test tumor tissue from patients with advanced cancers that may be enrolled in Phase 1 studies or other treatments. Researchers will study if the results from genetic testing can help researchers determine which therapy may prove more beneficial for a patient in the future.

Conditions

Interventions

PROCEDURE

Tumor Tissue

Tumor tissue collected previously from surgery or a prior biopsy (archived tissue) used for genetic testing.

Sponsors & Collaborators

Principal Investigators

  • Funda Meric-Bernstam, MD · M.D. Anderson Cancer Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-13
Primary Completion
2021-06-01
Completion
2021-06-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02437617 on ClinicalTrials.gov